435 related articles for article (PubMed ID: 34059012)
1. Predicting breast cancer drug response using a multiple-layer cell line drug response network model.
Huang S; Hu P; Lakowski TM
BMC Cancer; 2021 May; 21(1):648. PubMed ID: 34059012
[TBL] [Abstract][Full Text] [Related]
2. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
Wang L; Li X; Zhang L; Gao Q
BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
[TBL] [Abstract][Full Text] [Related]
3. Predicting drug response of tumors from integrated genomic profiles by deep neural networks.
Chiu YC; Chen HH; Zhang T; Zhang S; Gorthi A; Wang LJ; Huang Y; Chen Y
BMC Med Genomics; 2019 Jan; 12(Suppl 1):18. PubMed ID: 30704458
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agents.
Kadra G; Finetti P; Toiron Y; Viens P; Birnbaum D; Borg JP; Bertucci F; Gonçalves A
Breast Cancer Res Treat; 2012 Apr; 132(3):1035-47. PubMed ID: 21792624
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive anticancer drug response prediction based on a simple cell line-drug complex network model.
Wei D; Liu C; Zheng X; Li Y
BMC Bioinformatics; 2019 Jan; 20(1):44. PubMed ID: 30670007
[TBL] [Abstract][Full Text] [Related]
6. Predicting Anticancer Drug Responses Using a Dual-Layer Integrated Cell Line-Drug Network Model.
Zhang N; Wang H; Fang Y; Wang J; Zheng X; Liu XS
PLoS Comput Biol; 2015; 11(9):e1004498. PubMed ID: 26418249
[TBL] [Abstract][Full Text] [Related]
7. Widespread molecular patterns associated with drug sensitivity in breast cancer cell lines, with implications for human tumors.
Creighton CJ
PLoS One; 2013; 8(12):e71158. PubMed ID: 24386073
[TBL] [Abstract][Full Text] [Related]
8. ssGSEA score-based Ras dependency indexes derived from gene expression data reveal potential Ras addiction mechanisms with possible clinical implications.
Yi M; Nissley DV; McCormick F; Stephens RM
Sci Rep; 2020 Jun; 10(1):10258. PubMed ID: 32581224
[TBL] [Abstract][Full Text] [Related]
9. Identifying anti-cancer drug response related genes using an integrative analysis of transcriptomic and genomic variations with cell line-based drug perturbations.
Sun Y; Zhang W; Chen Y; Ma Q; Wei J; Liu Q
Oncotarget; 2016 Feb; 7(8):9404-19. PubMed ID: 26824188
[TBL] [Abstract][Full Text] [Related]
10. kESVR: An Ensemble Model for Drug Response Prediction in Precision Medicine Using Cancer Cell Lines Gene Expression.
Majumdar A; Liu Y; Lu Y; Wu S; Cheng L
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34070793
[TBL] [Abstract][Full Text] [Related]
11. Pan-Cancer Prediction of Cell-Line Drug Sensitivity Using Network-Based Methods.
Pouryahya M; Oh JH; Mathews JC; Belkhatir Z; Moosmüller C; Deasy JO; Tannenbaum AR
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163005
[TBL] [Abstract][Full Text] [Related]
12. Drug Intervention Response Predictions with PARADIGM (DIRPP) identifies drug resistant cancer cell lines and pathway mechanisms of resistance.
Brubaker D; Difeo A; Chen Y; Pearl T; Zhai K; Bebek G; Chance M; Barnholtz-Sloan J
Pac Symp Biocomput; 2014; ():125-35. PubMed ID: 24297540
[TBL] [Abstract][Full Text] [Related]
13. Super.FELT: supervised feature extraction learning using triplet loss for drug response prediction with multi-omics data.
Park S; Soh J; Lee H
BMC Bioinformatics; 2021 May; 22(1):269. PubMed ID: 34034645
[TBL] [Abstract][Full Text] [Related]
14. DROEG: a method for cancer drug response prediction based on omics and essential genes integration.
Wu P; Sun R; Fahira A; Chen Y; Jiangzhou H; Wang K; Yang Q; Dai Y; Pan D; Shi Y; Wang Z
Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36715269
[TBL] [Abstract][Full Text] [Related]
15. Clinical drug response prediction from preclinical cancer cell lines by logistic matrix factorization approach.
Emdadi A; Eslahchi C
J Bioinform Comput Biol; 2022 Apr; 20(2):2150035. PubMed ID: 34923927
[TBL] [Abstract][Full Text] [Related]
16. Deep learning assisted multi-omics integration for survival and drug-response prediction in breast cancer.
Malik V; Kalakoti Y; Sundar D
BMC Genomics; 2021 Mar; 22(1):214. PubMed ID: 33761889
[TBL] [Abstract][Full Text] [Related]
17. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
Wang Y; Yang Y; Chen S; Wang J
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
[TBL] [Abstract][Full Text] [Related]
18. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Barretina J; Caponigro G; Stransky N; Venkatesan K; Margolin AA; Kim S; Wilson CJ; Lehár J; Kryukov GV; Sonkin D; Reddy A; Liu M; Murray L; Berger MF; Monahan JE; Morais P; Meltzer J; Korejwa A; Jané-Valbuena J; Mapa FA; Thibault J; Bric-Furlong E; Raman P; Shipway A; Engels IH; Cheng J; Yu GK; Yu J; Aspesi P; de Silva M; Jagtap K; Jones MD; Wang L; Hatton C; Palescandolo E; Gupta S; Mahan S; Sougnez C; Onofrio RC; Liefeld T; MacConaill L; Winckler W; Reich M; Li N; Mesirov JP; Gabriel SB; Getz G; Ardlie K; Chan V; Myer VE; Weber BL; Porter J; Warmuth M; Finan P; Harris JL; Meyerson M; Golub TR; Morrissey MP; Sellers WR; Schlegel R; Garraway LA
Nature; 2012 Mar; 483(7391):603-7. PubMed ID: 22460905
[TBL] [Abstract][Full Text] [Related]
19. Integrated pan-cancer gene expression and drug sensitivity analysis reveals SLFN11 mRNA as a solid tumor biomarker predictive of sensitivity to DNA-damaging chemotherapy.
Shee K; Wells JD; Jiang A; Miller TW
PLoS One; 2019; 14(11):e0224267. PubMed ID: 31682620
[TBL] [Abstract][Full Text] [Related]
20. Computational Cancer Cell Models to Guide Precision Breast Cancer Medicine.
Cheng L; Majumdar A; Stover D; Wu S; Lu Y; Li L
Genes (Basel); 2020 Feb; 11(3):. PubMed ID: 32121160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
